LexDanaLexDanabeta
Inventor

ROMAN HILLIG

Inventor
DE

Overview

3→
Patents
2025–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
C07DHeterocyclic compounds43%
A61KPreparations for medical, dental or toiletry purposes14%
PatentTitleYear
12,565,496Substituted 1H-pyrrolo[3,2-b]pyridine compounds and methods of use thereof202612,357,603Acyl sulfonamides for treating cancer202512,227,5013-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors2025

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2025–2026Patents assigned to BAYER AG (3)· patent assignee history
2025–2026Patents assigned to BROAD INST INC (3)· patent assignee history
2025–2026Patents assigned to DANA FARBER CANCER INST INC (2)· patent assignee history
2025–2026Based in DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BAYER AG32025–2026
BROAD INST INC32025–2026
DANA FARBER CANCER INST INC22025–2026
Locations
LocationPatentsSpan
DE32025–2026